Non-invasive detection of latent cardiac conduction abnormalities in patients with pulmonary sarcoidosis - Application of signal averaged electrocardiogram

Circulation Journal

Volumn 71, Issue 4, 2007, Pages 540-545

  Yodogawa, Kenji ^a   Seino, Yoshihiko ^a   Ohara, Toshihiko ^a   Takayama, Hideo ^a   Kobayashi, Yoshinori ^a   Katoh, Takao ^a   Takano, Teruo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cardiac involvement; Late potentials; Sarcoidosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; SARCOIDOSIS; SIGNAL AVERAGED ELECTROCARDIOGRAPHY;

ACTION POTENTIALS; ADULT; AGED; ARRHYTHMIA; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; HEART; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDYL-DIPEPTIDASE A; SARCOIDOSIS, PULMONARY;

EID: 34047146424     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.540     Document Type: Article

References (28)

1. Newman LE, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-1234.
2. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: Diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996; 10: 495-510.
3. Deng JC, Baughman RP, Lynch JP III. Cardiac involvement in sarcoidosis. Semin Respir Crit Care Med 2002; 23: 513-528.
4. Yasutake H, Seino Y, Kashiwagi M, Honma H, Matsuzaki T, Takano T. Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter. Int J Cardiol 2005; 102: 259-268.
5. Silverman KJ, Hutchins JM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-1211.
6. Loncope WT, Freiman DGH. A study of sarcoidosis: Based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 1952; 31: 1-132.
7. Iwai K, Sekiguchi M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 1994; 11: 26-31.
8. Bargout R, Kelly RF. Sarcoid heart disease: Clinical course and treatment. Int J Cardiol 2004; 97: 173-182.
9. Breithardt G, Becker G, Seipel L, Abendroth RR, Ostermeyer J. Noninvasive detection of late potentials: A new marker for ventricular tachycardia. Eur Heart J 1981; 2: 1-11.
10. Kanovsky MS, Falcone RA, Dresden CA, Josephson ME, Simson MB. Identification of patients with ventricular tachycardia after myocardial infarction: Signal-averaged electrocardiogram, Holter monitoring, and cardiac catheterization. Circulation 1984; 70: 264-270.
11. Cripps TR, Counihan PJ, Frenneaux MP, Ward DE, Camm AJ, McKenna WJ. Signal-averaged electrocardiography in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15: 956-961.
12. Poll DS, Marchilinski FE, Falcone RA, Josephson ME, Simson MB. Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: Relationship to sustained ventricular tachyarrhythmias. Circulation 1985; 72: 1308-1313.
13. Mancini D, Wong KL, Simson MB. Prognostic value of an abnormal signal averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation 1993; 87: 1083-1092.
14. Shimada T, Shimada K, Sakane T, Ochiai K, Tsukihashi H, Fukui M, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001; 110: 520-527.
15. Gomes JA, Winters SL, Martinson M, Machac J, Stewart D, Targonski A. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: A prospective study. J Am Coll Cardiol 1989; 13: 377-384.
16. Kasahara Y, Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 1981; 27: 1922-1925.
17. Kinney EL, Caldwell JW. Do thallium myocardial perfusion scan abnormalities can predict survival in sarcoid patients without cardiac symptoms? Angiology 1990; 41: 573-576.
18. Smedema JP, Snoep G, Van Kroonenburgh, Van Geuns RJ, Dassen WR, Gorgels AP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-1690.
19. Gardner PI, Ursell PC, Pham TD, Fenoglio JJ, Witt AL. Electrographic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985; 72: 596-611.
20. Bulkley BH, Ridolfdi RL, Sayler WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis (scleroderma): Advances in clinical and pathologic features, pathogenesis, and new therapeutic approaches. Am Heart J 1981; 102: 913-919.
21. Mehta D, McKenna WJ, Ward DE, Davies MJ, Camm AJ. Significance of signal-averaged electrocardiography in relation to endmyocardial biopsy and ventricular stimulation studies in patients with ventricular tachycardia without clinically apparent heart disease. J Am Coll Cardiol 1989; 14: 372-379.
22. Suzuki T, Kanda T, Kubota S, Imai S, Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 1994; 106: 1021-1024.
23. Tsukamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-516.
24. Maeda K, Tsukamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-832.
25. Niinuma H, Nakamura M, Hiramori K. Plasma B-type natriuretic peptide measurement in a multiphasic health screening program. Cardiology 1998; 90: 89-94.
26. Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cadiol 2005; 96: 276-282.
27. Furushima H, Chinushi M, Sugiura H, Kasai H, Washizuka T, Aizawa Y. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: Its mechanisms and outcome. Clin Cardiol 2004; 27: 217-222.
28. Uyarel H, Uslu N, Okmen E, Tartan Z, Kasikcioqlu H, Davi SU, et al. QT dispersion in sarcoidosis. Chest 2005; 128: 2619-2625.